Related Experiment Video
Updated: Apr 8, 2026
05:39
Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines
Published on: October 30, 2018
12.8K
Using Plasmids as DNA Vaccines for Infectious Diseases
John S Tregoning1, Ekaterina Kinnear1
1Mucosal Infection and Immunity Group, Section of Virology, Imperial College London, St Mary's Campus, London W2 1PG, United Kingdom.
Microbiology Spectrum
|June 25, 2015
Summary
DNA vaccines utilize DNA plasmids to deliver genes for immune responses, offering potential for personalized and rapid mass vaccination. Despite early clinical trial challenges, advancements in delivery and adjuvants show promise for overcoming immunogenicity barriers.
Area of Science:
- Vaccinology
- Molecular Biology
- Immunology
Background:
- DNA plasmids can encode vaccine antigens to elicit protective immune responses.
- Naked DNA's ability to enter cells and express antigens is remarkable against pathogen defenses.
- DNA vaccines offer potential for low-cost, rapidly developed designer vaccines for diseases like cancer and pandemics.
Purpose of the Study:
- To review key concepts of DNA plasmid vaccines, including cellular entry, expression, and immune induction.
- To summarize clinical trial outcomes for DNA vaccines.
- To explore advancements in vector design, delivery, formulation, and adjuvants for DNA vaccine technology.
Main Methods:
- Review of existing literature on DNA vaccine technology.
- Analysis of cellular mechanisms of DNA vaccine uptake and expression.
- Summary and critique of clinical trial data for DNA vaccines.
- Exploration of current research in enhancing DNA vaccine efficacy.
Main Results:
- DNA vaccines face challenges in inducing potent immune responses, evidenced by clinical trial failures.
- Delivery systems like electroporation and inclusion of adjuvants are improving DNA vaccine expression levels.
- Ongoing research focuses on overcoming immunogenicity and expression barriers.
Conclusions:
- DNA vaccine technology holds significant promise for future vaccination strategies.
- Advancements in delivery, formulation, and adjuvant incorporation are crucial for realizing this potential.
- Successfully addressing immunogenicity and expression challenges could revolutionize mass vaccination.
Related Concept Videos
01:28Plasmids
4.0K
Plasmids are extrachromosomal DNA molecules found in bacteria, archaea, and some eukaryotic microbes like yeast. These small, circular DNA structures typically contain fewer than 30 genes, although some may exist linearly. Plasmids vary in their number within a cell, known as copy number. Single-copy plasmids are present in one copy per cell and multi-copy plasmids are present in multiple copies, reaching over 100 copies per cell.Plasmids usually replicate independently of the chromosomal DNA...
4.0K
01:33Bacterial Transformation
63.6K
In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
63.6K
01:26DNA Bacteriophages
1.5K
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
1.5K
01:21Vaccines
51
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
51
00:46Genomic DNA in Prokaryotes
50.8K
The genome of most prokaryotic organisms consists of double-stranded DNA organized into one circular chromosome in a region of cytoplasm called the nucleoid. The chromosome is tightly wound, or supercoiled, for efficient storage. Prokaryotes also contain other circular pieces of DNA called plasmids. These plasmids are smaller than the chromosome and often carry genes that confer adaptive functions, such as antibiotic resistance.
Genomic Diversity in Bacteria
Although bacterial genomes are much...
Genomic Diversity in Bacteria
Although bacterial genomes are much...
50.8K
01:29Microorganisms in Medicine and Therapeutics
1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K